ENDRA Life Sciences (NDRA) Construction in Progress (2019 - 2024)
ENDRA Life Sciences (NDRA) posted quarterly Construction in Progress of $125153.0 for Q3 2024, down 11.0% YoY from $140617.0 in Q4 2023, and little changed sequentially from $125151.0 in Q2 2024.
ENDRA Life Sciences (NDRA) Construction in Progress (2019 - 2024) Analysis & Trends
ENDRA Life Sciences has disclosed Construction in Progress across 6 years of filings, most recently posting $125153.0 for Q3 2024.
- In Q3 2024, Construction in Progress fell 11.0% year-over-year to $125153.0; the TTM figure through Sep 2024 stood at $125153.0 (down 11.0% YoY), while the FY2023 annual figure was $125151.0, down 11.0% from the prior year.
- Construction in Progress held at $125153.0 in Q3 2024, from $125151.0 in the prior quarter.
- Over the last five years, Construction in Progress for NDRA reached as high as $143482.0 in Q2 2022 and fell as low as $79207.0 in Q4 2020.
- The 5-year median for Construction in Progress is $125153.0 (2024), against an average of $126508.4.
- Annual changes were most pronounced in 2020 — Construction in Progress surged 81.68% — and 2023, when it retreated 11.0%.
- A 5-year view of Construction in Progress shows it stood at $79207.0 in 2020, then soared by 35.95% to $107682.0 in 2021, then jumped by 30.59% to $140617.0 in 2022, then retreated by 11.0% to $125151.0 in 2023, then advanced by 0.0% to $125153.0 in 2024.
- According to Business Quant data, Construction in Progress over the past three periods registered $125153.0, $125151.0, and $125151.0 for Q3 2024, Q2 2024, and Q1 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | - |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | - |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | - |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | - |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | - |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | - |
| 10 | ENDRA Life Sciences | 5.95 Mn | 5.59 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 125,153.00 |
| Jun 30, 2024 | 125,151.00 |
| Mar 31, 2024 | 125,151.00 |
| Dec 31, 2023 | 125,151.00 |
| Sep 30, 2023 | 140,617.00 |
| Jun 30, 2023 | 140,617.00 |
| Mar 31, 2023 | 140,617.00 |
| Dec 31, 2022 | 140,617.00 |
| Sep 30, 2022 | 143,482.00 |
| Jun 30, 2022 | 143,482.00 |
| Mar 31, 2022 | 107,682.00 |
| Dec 31, 2021 | 107,682.00 |
| Dec 31, 2020 | 79,207.00 |
| Dec 31, 2019 | 43,596.00 |